High prevalence of diagnosis of diabetes, depression, anxiety, hypertension, asthma and COPD in the total population of Stockholm, Sweden – a challenge for public health

BMC Public Health

Gunnar Ljunggren²  Björn Wettermark¹  Ramin Zarrinkoub⁶  Urban Ösby³  Per Wändell⁴  Axel C Carlsson⁵ 

[1] Centre for Pharmacoepidemiology and Department of Laboratory Medicine, Division of Clinical Pharmacology, Karolinska University Hospital, Huddinge, Sweden;Medical Management Centre, Department of Learning, Informatics, Management and Ethics, Karolinska Institutet, Berzelius väg 3, SE-17177 Stockholm, Sweden;Department of Psychiatry, Tiohundra AB, Norrtälje, Sweden;Centre for Family Medicine, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Alfred Nobels Allé 12, 141 83 Huddinge, Sweden;Department of Public Health and Caring Sciences/ Section of Geriatrics, Uppsala University, Uppsala, Sweden;Public Healthcare Services Committee Administration, Stockholm County Council, Box 6909, SE- 102 39 Stockholm, Sweden

关键词: Epidemiology;    Age differences;    Gender differences;    Primary care;    Administrative databases;   

Others  :  1162012
DOI  :  10.1186/1471-2458-13-670

 received in 2012-10-22, accepted in 2013-07-01,  发布年份 2013

【 摘 要 】

Background

There is limited knowledge on the prevalence of disease in total populations. Such studies have historically been difficult to conduct but the development of health data registers has facilitated large-scale studies on recorded diagnoses in entire regions. The aim of this study was to analyze the prevalence of diagnosis of six common diseases in the Swedish capital region.

Methods

The study population included all living persons who resided in Stockholm County, Sweden, on December 31^st 2011 (N = 2 093 717). Information on all consultations between 2007 and 2011 was obtained from primary health care, specialist outpatient care and inpatient care. Prevalence was defined as the proportion of individuals with a recorded diagnosis of diabetes, depression, anxiety disorders, hypertension, asthma and chronic obstructive pulmonary disease during the five year period, respectively. Analyses were done by age and gender.

Results

Hypertension had the highest five-year prevalence (12.2%), followed by depression (6.6%), diabetes mellitus (6.2%), asthma (5.9%), anxiety disorders/phobia (4.8%), and COPD (1.8%). Diabetes was more common in men (5.3% of women and 7.1% of men) while depression (8.7% in women and 4.4% in men) and anxiety (6.3% in women and 3.4% in men) were considerably more common in women. Smaller gender differences were also found for hypertension (13.0% in women and 11.4% in men), asthma (6.4% in women and 5.4% in men) and COPD (2.1% in women and 1.6% in men). Diabetes, hypertension and COPD increased markedly with age, whereas anxiety, depression and asthma were fairly constant in individuals above 18 years. During one year of observation, more than half of all patients had only been diagnosed in primary health care, with hypertension being the diagnosis with the largest proportion of patients only identified in primary health care (70.6%).

Conclusion

The prevalence of common diseases in the population can be estimated by combining data gathered during consecutive years from primary care, specialist outpatient care and inpatient care. However, accuracy of disease prevalence is highly dependent on the quality of the data. The high prevalence of the six diagnoses analysed in this study calls for preventive action to minimize suffering and costs to society.

【 授权许可】

   
2013 Carlsson et al.; licensee BioMed Central Ltd.

【 参考文献 】

• [1]Wandell PE, Johansson SE, Gafvels C, Hellenius ML, de Faire U, Sundquist J: Estimation of diabetes prevalence among immigrants from the Middle East in Sweden by using three different data sources. Diabetes Metab 2008, 34(4 Pt 1):328-333.
• [2]Rodriguez EM, Staffa JA, Graham DJ: The role of databases in drug postmarketing surveillance. Pharmacoepidemiol Drug Saf 2001, 10(5):407-410.
• [3]Sweden S: Statistical yearbook of Sweden 2011. Stockholm: Statistics Sweden; 2010.
• [4]Ludvigsson JF, Andersson E, Ekbom A, Feychting M, Kim JL, Reuterwall C, Heurgren M, Olausson PO: External review and validation of the Swedish national inpatient register. BMC Publ Health 2011, 11:450. BioMed Central Full Text
• [5]Rosen M: National health data registers: a Nordic heritage to public health. Scand J Public Health 2002, 30(2):81-85.
• [6]Nilsson G, Ahlfeldt H, Strender LE: Textual content, health problems and diagnostic codes in electronic patient records in general practice. Scand J Prim Health Care 2003, 21(1):33-36.
• [7]Wirehn AB, Karlsson HM, Carstensen JM: Estimating disease prevalence using a population-based administrative healthcare database. Scand J Public Health 2007, 35(4):424-431.
• [8]Sorensen HT, Sabroe S, Olsen J: A framework for evaluation of secondary data sources for epidemiological research. Int J Epidemiol 1996, 25(2):435-442.
• [9]Ekman I, Wolf A, Olsson LE, Taft C, Dudas K, Schaufelberger M, Swedberg K: Effects of person-centred care in patients with chronic heart failure: the PCC-HF study. Eur Heart J 2012, 33(9):1112-1119.
• [10]Burstrom B: Will Swedish healthcare reforms affect equity? BMJ 2009, 339:b4566.
• [11]Lofgren S, Ljunggren G, Brommels M: No ticking time bomb: hospital utilisation of 28,528 hip fracture patients in Stockholm during 1998–2007. Scand J Public Health 2010, 38(4):418-425.
• [12]Rydholm A, Ljunggren G, Grafström M, Strömberg L: Dementia, delirium and other co-morbid conditions in acute hip fracture care – traditions, attitudes and local policies rather than actual state guide diagnose making? Vårdi Norden 2005, 25(4):25-29.
• [13]Lokk J, Borg S, Svensson J, Persson U, Ljunggren G: Drug and treatment costs in Parkinson’s disease patients in Sweden. ActaNeurol Scand 2012, 125(2):142-147.
• [14]Carlsson AC, Wandell PE, de Faire U, Hellenius ML: Prevalence of hypertension in immigrants and Swedish-born individuals, a cross-sectional study of 60-year-old men and women in Sweden. J Hypertens 2008, 26(12):2295-2302.
• [15]Wandell PE, Carlsson AC, de Faire U, Hellenius ML: Prevalence of blood lipid disturbances in Swedish and foreign-born 60-year-old men and women in Stockholm, Sweden. NutrMetab Cardiovasc Dis 2011, 21(3):173-181.
• [16]Carlsson AC, Theobald H, Wandell PE: Health factors and longevity in men and women: a 26-year follow-up study. Eur J Epidemiol 2010, 25(8):547-551.
• [17]Nilsson J, Ostling S, Waern M, Karlsson B, Sigstrom R, Guo X, Skoog I: The 1-month prevalence of generalized anxiety disorder according to DSM-IV, DSM-V, and ICD-10 among nondemented 75-year-olds in Gothenburg, Sweden. Am J Geriatr Psychiatry 2012, 20(11):963-972.
• [18]Wallerblad A, Moller J, Forsell Y: Care-seeking pattern among persons with depression and anxiety: a population-based study in Sweden. Int J Family Med 2012, 2012:895425.
• [19]Wandell PE, Gafvels C: Patients with type 2 diabetes aged 35–64 years at four primary health care centres in Stockholm County, Sweden. Prevalence and complications in relation to gender and socio-economic status. Diabetes Res Clin Pract 2004, 63(3):195-203.
• [20]Gale EA, Gillespie KM: Diabetes and gender. Diabetologia 2001, 44(1):3-15.
• [21]Jansson SP, Andersson DK, Svardsudd K: Prevalence and incidence rate of diabetes mellitus in a Swedish community during 30 years of follow-up. Diabetologia 2007, 50(4):703-710.
• [22]Wandell PE, Carlsson A, Steiner KH: Prevalence of diabetes among immigrants in the Nordic countries. Curr Diabetes Rev 2010, 6(2):126-133.
• [23]Patten SB, Stuart HL, Russell ML, Maxwell CJ, Arboleda-Florez J: Epidemiology of major depression in a predominantly rural health region. Soc Psychiatry Psychiatr Epidemiol 2003, 38(7):360-365.
• [24]Andersson D, Magnusson H, Carstensen J, Borgquist L: Co-morbidity and health care utilisation five years prior to diagnosis for depression. A register-based study in a Swedish population. BMC Publ Health 2011, 11:552. BioMed Central Full Text
• [25]Egan BM, Zhao Y, Axon RN: US trends in prevalence, awareness, treatment, and control of hypertension, 1988–2008. JAMA 2010, 303(20):2043-2050.
• [26]Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J: Global burden of hypertension: analysis of worldwide data. Lancet 2005, 365(9455):217-223.
• [27]Joffres MR, Hamet P, MacLean DR, L'Italien GJ, Fodor G: Distribution of blood pressure and hypertension in Canada and the United States. Am J Hypertens 2001, 14(1 Pt 1):1099-1105.
• [28]Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G, Grassi G, Heagerty AM, Kjeldsen SE, Laurent S, et al.: 2007 Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J 2007, 28(12):1462-1536.
• [29]Vasan RS, Beiser A, Seshadri S, Larson MG, Kannel WB, D'Agostino RB, Levy D: Residual lifetime risk for developing hypertension in middle-aged women and men: the Framingham heart study. JAMA 2002, 287(8):1003-1010.
• [30]Marques-Vidal P, Tuomilehto J: Hypertension awareness, treatment and control in the community: is the ‘rule of halves’ still valid? J Hum Hypertens 1997, 11(4):213-220.
• [31]Wolf-Maier K, Cooper RS, Banegas JR, Giampaoli S, Hense HW, Joffres M, Kastarinen M, Poulter N, Primatesta P, Rodriguez-Artalejo F, et al.: Hypertension prevalence and blood pressure levels in 6 European countries, Canada, and the United States. JAMA 2003, 289(18):2363-2369.
• [32]Anandan C, Nurmatov U, van Schayck OC, Sheikh A: Is the prevalence of asthma declining? Systematic review of epidemiological studies. Allergy 2010, 65(2):152-167.
• [33]Osborne ML, Vollmer WM, Linton KL, Buist AS: Characteristics of patients with asthma within a large HMO: a comparison by age and gender. Am J Respir Crit Care Med 1998, 157(1):123-128.
• [34]Weiner P, Magadle R, Massarwa F, Beckerman M, Berar-Yanay N: Influence of gender and inspiratory muscle training on the perception of dyspnea in patients with asthma. Chest 2002, 122(1):197-201.
• [35]Ballardini N, Kull I, Lind T, Hallner E, Almqvist C, Ostblom E, Melen E, Pershagen G, Lilja G, Bergstrom A, et al.: Development and comorbidity of eczema, asthma and rhinitis to age 12: data from the BAMSE birth cohort. Allergy 2012, 67(4):537-544.
• [36]Wandell PE, Carlsson AC, Sundquist K, Johansson SE, Sundquist J: Total mortality among levothyroxine-treated women with atrial fibrillation in Swedish primary health care. Int J Cardiol 2011, 152(1):147-148.
• [37]Hjerpe P, Merlo J, Ohlsson H, Bengtsson Bostrom K, Lindblad U: Validity of registration of ICD codes and prescriptions in a research database in Swedish primary care: a cross-sectional study in Skaraborg primary care database. BMC Med Inform Decis Mak 2010, 10:23. BioMed Central Full Text
• [38]Forrest CB: Primary care in the United States: primary care gatekeeping and referrals: effective filter or failed experiment? BMJ 2003, 326(7391):692-695.
• [39]Nazir A, Papita R, Anbalagan VP, Anjana RM, Deepa M, Mohan V: Prevalence of diabetes in Asian Indians based on glycated hemoglobin and fasting and 2-h post-load (75-g) plasma glucose (CURES-120). Diabetes Technol Ther 2012, 14(8):665-668.